StockData
GMABNasdaqPharmaceutical PreparationsAlso trades as GNMSF

GENMAB A/S

Financials through fiscal 2025, year ended Dec 31, 2025
$38.50+1.50 (+4.05%)

Close on Oct 19, 2026

GENMAB A/S revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Genmab A/S does not break out revenue by segment, region or product in the tagged data of its filings for this period type.